Literature DB >> 30190827

Is histopathological overdiagnosis of melanoma a good insurance for the future?

Gerardo Ferrara1,1, Iris Zalaudek2,2.   

Abstract

Entities:  

Keywords:  histopathological diagnosis; histopathological overdiagnosis; medicolegal claims; melanocytic nevus; melanoma

Year:  2015        PMID： 30190827      PMCID： PMC6094704          DOI： 10.2217/mmt.14.29

Source DB:  PubMed          Journal:  Melanoma Manag        ISSN： 2045-0885


× No keyword cloud information.
  10 in total

1.  Pseudomelanoma: recurrent melanocytic nevus following partial surgical removal.

Authors:  R Kornberg; A B Ackerman
Journal:  Arch Dermatol       Date:  1975-12

2.  Lentiginous melanoma: a distinctive clinicopathological entity.

Authors:  G Ferrara; I Zalaudek; G Argenziano
Journal:  Histopathology       Date:  2008-03       Impact factor: 5.087

3.  "Clark/dysplastic" nevi with florid fibroplasia associated with pseudomelanomatous features.

Authors:  Christine J Ko; Jean L Bolognia; Earl J Glusac
Journal:  J Am Acad Dermatol       Date:  2011-02       Impact factor: 11.527

4.  The melanoma 'epidemic', a dermatopathologist's perspective.

Authors:  Earl J Glusac
Journal:  J Cutan Pathol       Date:  2011-03       Impact factor: 1.587

5.  Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

Authors:  Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Omgo E Nieweg; Daniel F Roses; Harold J Hoekstra; Constantine P Karakousis; Christopher A Puleo; Brendon J Coventry; Mohammed Kashani-Sabet; B Mark Smithers; Eberhard Paul; William G Kraybill; J Gregory McKinnon; He-Jing Wang; Robert Elashoff; Mark B Faries
Journal:  N Engl J Med       Date:  2014-02-13       Impact factor: 91.245

6.  Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes.

Authors:  Alexander C J van Akkooi; Zbigniew I Nowecki; Christiane Voit; Gregor Schäfer-Hesterberg; Wanda Michej; Johannes H W de Wilt; Piotr Rutkowski; Cornelis Verhoef; Alexander M M Eggermont
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

7.  Pitfalls in the diagnosis of malignant melanoma: findings of a risk management panel study.

Authors:  David B Troxel
Journal:  Am J Surg Pathol       Date:  2003-09       Impact factor: 6.394

8.  Final version of 2009 AJCC melanoma staging and classification.

Authors:  Charles M Balch; Jeffrey E Gershenwald; Seng-Jaw Soong; John F Thompson; Michael B Atkins; David R Byrd; Antonio C Buzaid; Alistair J Cochran; Daniel G Coit; Shouluan Ding; Alexander M Eggermont; Keith T Flaherty; Phyllis A Gimotty; John M Kirkwood; Kelly M McMasters; Martin C Mihm; Donald L Morton; Merrick I Ross; Arthur J Sober; Vernon K Sondak
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544

9.  Slowing the growth of health care costs--lessons from regional variation.

Authors:  Elliott S Fisher; Julie P Bynum; Jonathan S Skinner
Journal:  N Engl J Med       Date:  2009-02-26       Impact factor: 91.245

10.  Recurrent melanocytic nevi and melanomas in dermoscopy: results of a multicenter study of the International Dermoscopy Society.

Authors:  Andreas Blum; Rainer Hofmann-Wellenhof; Ashfaq A Marghoob; Giuseppe Argenziano; Horacio Cabo; Cristina Carrera; Bianca Costa Soares de Sá; Eric Ehrsam; Roger González; Josep Malvehy; Ausilia Maria Manganoni; Susana Puig; Olga Simionescu; Masaru Tanaka; Luc Thomas; Isabelle Tromme; Iris Zalaudek; Harald Kittler
Journal:  JAMA Dermatol       Date:  2014-02       Impact factor: 10.282
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.